期刊文献+

哺乳动物细胞西尼罗病毒样颗粒表达、纯化及其鉴定 被引量:1

Expression,purification and identification of West Nile virus-like particles in mammalian cells
原文传递
导出
摘要 目的利用哺乳动物细胞表达含有西尼罗病毒(WNV)prM和E蛋白,形成病毒样颗粒(virus-like particles,VLPs),为西尼罗病毒感染的免疫诊断试剂的研制奠定基础。方法筛选典型西尼罗病毒株,构建重组质粒,转染293T细胞,表达并纯化西尼罗病毒prM-E蛋白,利用透射电镜、免疫印迹试验、间接免疫荧光实验(IFA)和酶链免疫吸附试验(ELISA)对表达产物进行鉴定。结果重组质粒转染细胞后产生病毒样颗粒(viruslike particles VLPs),转染细胞上清纯化物中透射电镜观察到重组蛋白形成的球型颗粒,免疫印迹试验和间接免疫荧光试验表明,表达的病毒样颗粒蛋白能够与抗西尼罗病毒抗体特异结合,具有良好的抗原性;间接ELISA证实,重组蛋白可以作为抗原用于检测患者血清特异性抗体。结论在哺乳动物细胞中表达的西尼罗病毒样颗粒具有良好的抗原性,为西尼罗病毒感染快速特异诊断试剂研制奠定了基础。 Objective To express prM-E protein of West Nile virus in mammalian cells,which can assemble and form virus-like particles for further immunological diagnostic studies. Methods Virus-like particles of West Nile virus were expressed in 293T cell tranfeeted with the recombinant PreM-E plasmid, which followed with identification tests with transmission electron mieroseope(TEM), western-blotting(WB), immunofluorescence assay (IFA)and ELISA. Results Recombinant subviral particles, aboutS0 nm in diameter, were observed by TEM in the supernatant of transfected cells, which indicated that the transfected cells can secrete virus-like particles (VLPs) of WNV. The results of Western-blot, IFA and ELISA imply the recombinant proteins retained immunoreaetivity similar to those of native virus proteins Conclusion West Nile virus-like particles expressed in mammalian ee,lls retains good antigenicity,and lay a basis for further study on the immunoassay of West Nile virus infection and development of specific diagnostic reagents.
出处 《中国国境卫生检疫杂志》 CAS 2011年第2期85-88,共4页 Chinese Journal of Frontier Health and Quarantine
基金 国家公益性行业科研专项(200810162) 国家质检总局科研基金项目(2008IK210)
关键词 西尼罗病毒 293T细胞 prM—E蛋白 病毒样颗粒 间接免疫荧光试验 West Nile virus 293T cell prM-E VLPs IFA
  • 相关文献

参考文献14

  • 1Petersen L R, Roehrig J T, Hughes J M. West Nile virus encepha- litis[J]. N Engl J Med. 2002, 347(16): 1225-1226.
  • 2Campbell G L, Marfin A A, Lanciotti R S, et al. West Nile virus. Lancet Infect Dis[J]. 2002, 2(9): 519-529.
  • 3Lindenbach Brett D, Rice, C M. Fields Virology[M]. 4th ed NewY- ork: Raven Press, 2001.
  • 4Gubler DJ. Human Arboviral Infections Worldwide[J]. Ann NY Acacl Sci, 2001, 951:13-24.
  • 5Guble DJ. The global emergence/resurgence of arboviral diseases as public health problem[J]. Arch Med Res, 2002,33(4):330-342.
  • 6何竞,张贺秋.西尼罗病毒的生物学特性及实验室检测[J].军事医学科学院院刊,2007,31(1):78-82. 被引量:5
  • 7任军.西尼罗病毒研究进展[J].生命科学,2005,17(5):445-448. 被引量:6
  • 8Brinton MA. The molecular biology of West Nile Virus: a new in- vader of the western hemisphere [J]. Annu Rev Microbiol,2002,56: 371-402.
  • 9Heinz FX. Allison SL. Structures and mechanisms in flavivirus fu- sion[J]. Adv Virus Res,2002,55(6):231-269.
  • 10Ann R. Hunt, C. Bruce Cropp, Gwong-Jen J. ChangA,et al. re- combinant particulate antigen of Japanese encephalitis virus pro- duced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen[J]. J Virol Methods, 2001,97 (1):133-149.

二级参考文献54

  • 1Southam C M, Moore A E. Induced virus infections in man by the Egypt isolates of West Nile virus. Am J Trop Med Hyg, 1954, 3(1): 19-50.
  • 2Burke S D, Monath T P. Chapter 33: Flaviviruses[A]. In:Knipe D M, Howley PM, Griffin DE, et al. ed. Fields Virology (fourth edition) [M]. Philadelphia: Lippincott Williams & Wilkins, 2001.
  • 3Petersen L R, Martin A A. West Nile virus: a primer for the clinician. Ann Int Med, 2002, 137(3): 173-179.
  • 4Zeller H G, Schuffenecker I. West Nile virus: an overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas. Eur J Microbiol Infect Dis,2004, 23(2): 147-156.
  • 5Campbell G L, Martin A A, Lanciotti R S, et al. West Nile virus. Lancet Infect Dis, 2002, 2(9): 519-529.
  • 6Hammon W M, Sather G G. Immunity of hamsters to West Nile and Murray Valley viruses following immunization with St. Louis and Japanese B. Proc Soc Exp Biol Med, 1956, 91(3): 521-524.
  • 7Kanesa-Thasan N, Putnak J R, Mangiafico J A, et al. Absence of protective neutralizng antibodies to West Nile virus in subjects following vaccination with Japanese encephalitis or dengue vaccines. Am J Trop Med Hyg, 2002, 66(2):115-116.
  • 8Granwehr B P, Lillibridge K M, Higgs S, et al. West Nile virus: where are we now? Lancet Infect Dis, 2004, 4(9):547-556.
  • 9Gould L H, Fikrig E. West Nile virus: a growing concern? J Clin Invest, 2004, 113(8): 1102-1107.
  • 10Centers for Disease Control and Prevention (CDC). Update:Detection of West Nile virus in blood donations - United States, 2003. MMWR Morb Mortal Wkly Rep, 2003, 52:916,-919.

共引文献9

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部